Free provider profile
LYNSEY LAKIN, FNP-C
Need more providers like LYNSEY LAKIN?
See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.
Rep intel
What LYNSEY LAKIN prescribes and who else does
Top Medicare Part D drugs by claims (public CMS data):
- Kesimpta Pen
- Gammagard Liquid
- Octagam
- Botox
- Tysabri
Your next referral list starts here
Provider + market indicator
A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.
Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.
Practice contact card
Practice phone
626-598-3770
Fax
909-946-9931
Practice address
1015 N 1ST AVE APT A, ARCADIA, CA, 91006
- Registry updated
- 2023-11-08
- NPI issued
- 2014-12-19
- RepVector retrieved
- 11/21/2026
A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.
Registry record
Source: CMS NPPES registry.
1015 N 1ST AVE APT A, ARCADIA, CA, 91006
626-598-3770
Single practice location
Enumerated 2014-12-19
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — 2 taxonomies listed — broader service mix.
- — Record last updated 3 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
1,860
Medicare patients
179
Part D drug cost
$4,884,881
Brand-name share
27.5%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Mavenclad (Cladribine) | 12 | $826,757 |
| Kesimpta Pen (Ofatumumab) | 69 | $676,669 |
| Ocrevus (Ocrelizumab) | 15 | $552,377 |
| Octagam (Immun Globg(Igg)/Malt/Iga Ov50) | 52 | $368,106 |
| Gammagard Liquid (Immun Glob G(Igg)/Gly/Iga Ov50) | 53 | $335,038 |
| Vumerity (Diroximel Fumarate) | 18 | $238,765 |
| Tysabri (Natalizumab) | 19 | $153,843 |
| Botox (Onabotulinumtoxina) | 32 | $49,724 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Latest Medicare Part B billing
CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.
Loading the latest published CMS billing file…
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
Checking Open Payments…
Industry payments across CA — which companies pay providers there.
Open Payments page for this provider
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.
